STOCK TITAN
  1. Home
  2. News
  3. CVS

CVS Health Corp - CVS STOCK NEWS

Welcome to our dedicated news page for CVS Health (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on CVS Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CVS Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CVS Health's position in the market.

News
CVS Health to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
Rhea-AI Summary
CVS Health CEO and CFO to participate in fireside chat with investors at Morgan Stanley Global Healthcare Conference on September 12, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
News
CVS Health Launches Cordavis
Rhea-AI Summary
CVS Health launches Cordavis subsidiary to bring biosimilar products to market, starting with Hyrimoz® at over 80% lower list price than Humira®
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
-
News
CVS Health reports second quarter results
Rhea-AI Summary
CVS Health Corporation® reports Q2 2023 operating results with total revenues of $88.9 billion, up 10.3% YoY. GAAP diluted EPS is $1.48 and Adjusted EPS is $2.21. Full-year 2023 guidance is revised to $6.53 to $6.75 for GAAP EPS and confirmed at $8.50 to $8.70 for Adjusted EPS.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
earnings
News
Signify Health Launches Chronic Kidney Disease Testing, Expands In-Home Diagnostic and Preventive Services Offering
Rhea-AI Summary
Signify Health, a CVS Health company, has added a comprehensive in-home kidney health evaluation to its Diagnostic and Preventive Services offering. The new screenings aim to support the early detection and management of Chronic Kidney Disease (CKD), which affects an estimated 37 million U.S. adults. The evaluations provide clinicians and members with information to determine the best treatment and management plan, potentially including additional testing, lifestyle changes, pharmacological treatment, and referrals to nephrologists. The expanded offering aligns with new quality measures added by the Centers for Medicare and Medicaid Services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
News
CVS Pharmacy introduces new universal tools collection from one+other
Rhea-AI Summary
CVS Pharmacy (CVS) introduces the inclusively designed Universal Tools collection under its one+other beauty and personal care brand, catering to the diverse needs of its consumer base. The collection aims to make self-care more accessible for people with disabilities, featuring six universally comfortable self-care tools. The tools are available on CVS.com and in-store nationwide, furthering the retailer's commitment to inclusivity and accessibility in the self-care aisle.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
News
CVS Pharmacy introduces new universal tools collection from one+other
Rhea-AI Summary
CVS Pharmacy (CVS) expands one+other beauty and personal care brand with Universal Tools collection, designed for inclusivity and accessibility. The collection features six self-care tools with inclusive features, now available online and in-store nationwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
none
News
CVS Health appoints Scott Kirby to Board of Directors
Rhea-AI Summary
CVS Health Corporation (NYSE: CVS) appoints J. Scott Kirby, CEO of United Airlines Holdings, Inc., to its Board of Directors. Kirby's expertise in technology and leadership in a highly regulated, consumer-driven industry will advance CVS Health's technology-forward approach to improving consumer health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
management
-
News
CVS Caremark and GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members
Rhea-AI Summary
CVS Caremark and GoodRx have launched Caremark Cost Saver, a prescription drug discount solution aimed at lowering pharmacy out-of-pocket costs for CVS Caremark clients' members. The program provides automatic access to GoodRx's prescription pricing, allowing members to pay lower prices on generic medications. The amount paid will be applied to plan members' deductible and out-of-pocket thresholds. No action is required by the plan member.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none
-
News
CVS Health announces quarterly dividend
Rhea-AI Summary
CVS Health (NYSE: CVS) approves quarterly dividend of $0.605 per share on Common Stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
dividends
News
CVS Health to Hold Second Quarter 2023 Earnings Conference Call
Rhea-AI Summary
CVS Health will hold a conference call to discuss second quarter 2023 financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
earnings
Stock CVS logo
CVS Health Corp

NYSE:CVS

CVS Rankings

#136 Ranked by Market Cap
#3858 Ranked by Stock Gains
#864 Ranked by Dividends

CVS Stock Data

86.52B
1.25B
0.12%
82.88%
1.8%
Pharmacies and Drug Stores
Retail Trade
Link
US
Woonsocket

About CVS

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.